bioRxivBioinformaticsPreprint
A new insight for the screening of potential β-lactamase inhibitors
Abstract
The {beta}-lactamase produces by Aeromonas hydrophila which enables to hydrolyze and inactivate {beta}- lactam ring of antibiotics. The homology modeling was used to generate the 3-D model of {beta}-lactamase by using known template 3-D structure. The stereochemical quality and torsion angle of 3-D model were validated. Total eleven effective drugs have been selected and targeted the active amino acid residues in {beta}-lactamase. The drugs were derivative of {beta}-lactam ring antibiotics and screening was made by docking. Out of 11 drugs, 3 drugs (Ampicillin, Astreonam and Sultamicillin) were found to be more potent on the basis of robust binding energy between protein-drug interactions. Additionally, homology of {beta}-lactamase of A. hydrophila resembled with other pathogenic bacteria that used for phylogeny analysis. These findings suggest a new insight for better understanding and useful for designing of novel potent drugs.
- organism: bacteria (other)
- assay: protein structure
- research focus: drug response / drug discovery
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Impact of different amino acid substitutions in penicillin-binding protein 3 on beta-lactam susceptibility in Haemophilus influenzae
- Single-Domain Antibodies as Potent Inhibitors of Clinically Relevant β-Lactamases in Multidrug-Resistant Bacteria
Paloma Osset-Trénor, Markus Proft, Amparo Pascual‐Ahuir·Frontiers in MicrobiologyPeer-reviewed·Jun 10, 2026
- Binding mode of isoxazolyl penicillins to a Class-A beta-lactamase at ambient conditions
Gargi Gore, Andreas Prester, … Eike C. Schulz·Communications ChemistryPeer-reviewed·Dec 1, 2025
- Escape mutations circumvent a tradeoff between resistance to beta-lactams and a beta-lactamase inhibitor
D. Russ, F. Glaser, … R. Kishony·bioRxiv·Aug 9, 2019
- An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting
Addison M. Duda, Helena R. Ma, … Katherine J. Franz·ACS Infectious DiseasesPeer-reviewed·Jun 12, 2025
- Structure and mechanism of potent bifunctional β-lactam- and homoserine lactone-degrading enzymes from marine microorganisms
C. Selleck, M. Monteiro Pedroso, … G. Schenk·Scientific ReportsPeer-reviewed·Jul 30, 2020